2026 Global: Biopsy Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Biopsy Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Becton, Dickinson and Company (BD) is a leading global medical technology firm headquartered in Franklin Lakes, United States, with a broad portfolio of biopsy needles, core biopsy devices, and related consumables used in pathology and intraoperative workflows. Johnson & Johnson (Ethicon) dominates biopsy technology through the Mammotome Breast Biopsy System and related needle sets, reflecting its headquarters in New Brunswick, United States. Hologic, Inc., headquartered in Marlborough, United States, leads in breast and molecular biopsy device markets with vacuum-assisted breast biopsy systems, imaging-guided biopsy workflows, and pathology solutions. Cook Medical, based in Bloomington, United States, concentrates on minimally invasive biopsy devices including core needle systems and specialized guidance tools, serving hospitals and clinics worldwide. These devices span diagnostic and interventional pathways, enabling targeted sampling, rapid pathology reporting, and facilitating personalized treatment planning. The market is characterized by continuous miniaturization, improved imaging integration, and sterile single-use disposables. This market remains highly dynamic.
Merit Medical Systems, based in South Jordan, Utah, United States, is a major supplier of core needle biopsy products, vacuum-assisted systems, and biopsy-guidance accessories, serving teaching hospitals and outpatient centers worldwide. Argon Medical Devices, headquartered in Plano, Texas, United States, offers a broad portfolio of biopsy needles, access devices, and disposable components used in interventional radiology and surgical pathology. Olympus Corporation, headquartered in Tokyo, Japan, expands the biopsy devices market through endoscopic biopsy forceps, needles, and related imaging-guided tooling that enable tissue sampling across GI, respiratory, and urology procedures. Terumo Corporation, also based in Tokyo, Japan, contributes with a wide range of biopsy needles, guidewings, and accessories that support minimally invasive diagnostic workflows and biopsy-guided interventions globally. These companies collectively extend access to diverse biopsy modalities, from minimally invasive endoscopy to image-guided percutaneous sampling, while emphasizing sterilization, ergonomic design, and compatibility with hospital supply chains.
Fujifilm Holdings Corporation, headquartered in Tokyo, Japan, contributes to the biopsy devices market primarily through endoscopic biopsy forceps, needle sets, and imaging-compatible accessories deployed across gastroenterology, pulmonology, and urology procedures. Leica Biosystems, headquartered in Nussloch, Germany, expands biopsy capabilities within the pathology and histology continuum, offering cryostat systems, microtomes, and ancillary devices used to process biopsy specimens for histopathology and molecular analysis. The synergies among these firms, with the leaders described earlier, underscore a diversified market in which end-users value sterile, compact, and interoperable devices that minimize procedure time and maximize diagnostic yield. Through ongoing investment in ergonomics, single-use disposables, and compatibility with electronic health records, the Biopsy Devices Market is poised for continued growth across oncology, infectious disease, and regenerative medicine applications.
Becton, Dickinson and Company (BD) is a leading global medical technology firm headquartered in Franklin Lakes, United States, with a broad portfolio of biopsy needles, core biopsy devices, and related consumables used in pathology and intraoperative workflows. Johnson & Johnson (Ethicon) dominates biopsy technology through the Mammotome Breast Biopsy System and related needle sets, reflecting its headquarters in New Brunswick, United States. Hologic, Inc., headquartered in Marlborough, United States, leads in breast and molecular biopsy device markets with vacuum-assisted breast biopsy systems, imaging-guided biopsy workflows, and pathology solutions. Cook Medical, based in Bloomington, United States, concentrates on minimally invasive biopsy devices including core needle systems and specialized guidance tools, serving hospitals and clinics worldwide. These devices span diagnostic and interventional pathways, enabling targeted sampling, rapid pathology reporting, and facilitating personalized treatment planning. The market is characterized by continuous miniaturization, improved imaging integration, and sterile single-use disposables. This market remains highly dynamic.
Merit Medical Systems, based in South Jordan, Utah, United States, is a major supplier of core needle biopsy products, vacuum-assisted systems, and biopsy-guidance accessories, serving teaching hospitals and outpatient centers worldwide. Argon Medical Devices, headquartered in Plano, Texas, United States, offers a broad portfolio of biopsy needles, access devices, and disposable components used in interventional radiology and surgical pathology. Olympus Corporation, headquartered in Tokyo, Japan, expands the biopsy devices market through endoscopic biopsy forceps, needles, and related imaging-guided tooling that enable tissue sampling across GI, respiratory, and urology procedures. Terumo Corporation, also based in Tokyo, Japan, contributes with a wide range of biopsy needles, guidewings, and accessories that support minimally invasive diagnostic workflows and biopsy-guided interventions globally. These companies collectively extend access to diverse biopsy modalities, from minimally invasive endoscopy to image-guided percutaneous sampling, while emphasizing sterilization, ergonomic design, and compatibility with hospital supply chains.
Fujifilm Holdings Corporation, headquartered in Tokyo, Japan, contributes to the biopsy devices market primarily through endoscopic biopsy forceps, needle sets, and imaging-compatible accessories deployed across gastroenterology, pulmonology, and urology procedures. Leica Biosystems, headquartered in Nussloch, Germany, expands biopsy capabilities within the pathology and histology continuum, offering cryostat systems, microtomes, and ancillary devices used to process biopsy specimens for histopathology and molecular analysis. The synergies among these firms, with the leaders described earlier, underscore a diversified market in which end-users value sterile, compact, and interoperable devices that minimize procedure time and maximize diagnostic yield. Through ongoing investment in ergonomics, single-use disposables, and compatibility with electronic health records, the Biopsy Devices Market is poised for continued growth across oncology, infectious disease, and regenerative medicine applications.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
